Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Disposition to Issuer of 141,023 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 141,023 | n/a |
| Jun 12, 2026 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 77,000 | n/a |
| Jun 1, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 79,873 | n/a |
| Jun 12, 2025 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| Jun 2, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 33,000 | n/a |
| Aug 29, 2024 | Milestone Pharmaceuticals Inc. (MIST) | Grant/Award | 40,000 | n/a |
| Aug 26, 2024 | AGILE THERAPEUTICS INC (AGRX) | Disposition to Issuer | 976 | $1.5K |
| Jun 20, 2024 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/Award | 2,300 | n/a |
| May 24, 2024 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 23,000 | n/a |
| Jan 19, 2024 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/Award | 4,600 | n/a |